Dr Jack Wallace
Senior Research Officer
Working groups

Background
Dr Jack Wallace's research looks at hepatitis B as a phenomenon where the biomedical, social, economic and political intersect, and investigates how viral hepatitis affects individuals and communities and shapes social relations and social practices. His projects have included needs assessments of hepatitis B in Australia and China, policy assessments of viral hepatitis in Taiwan, Indonesia and Tasmania, and investigations into how people with hepatitis B and health care workers understand and respond to hepatitis B.
He has worked in community, government and research sectors seeking to reduce the personal and community impact of blood borne viruses, particularly viral hepatitis. His role prior to undertaking research work was establishing the national peak organisation representing people living with viral hepatitis, Hepatitis Australia where he was the Executive Officer between 1998 and 2005. Jack's previous positions included managing a peer-based injecting drug user organisation in Queensland and as the Principal Program Advisor – Hepatitis C, for Queensland Health.
Jack is the Chief Investigator on two Australian Research Council projects: Strengthening Community Responses to Chronic Hepatitis B, and “my health, our family”. Both of these projects looks at different aspects of the familial, social and cultural responses of hepatitis B to support the development of better public health policy, both nationally and internationally.
Qualifications
- PhD, La Trobe University
- Master of Social Sciences (International Development), RMIT
Appointments
- Adjunct Research Fellow, La Trobe University
- Adjunct Lecturer, Centre for Social Research in Health, UNSW Arts and Social Sciences
- Executive and Founding member, Coalition to Eradicate Viral Hepatitis in Asia Pacific (CEVHAP)
Positions
- 2018, Senior Research Officer, Burnet Institute
- 2007 - 2017, Research Fellow, Australian Research Centre in Sex, Health and Society
- 1998- 2004, Executive Officer, Hepatitis Australia
- 1996-1998, Principal Program Adviser (Hepatitis C), Queensland Health
Reports + Policy Briefs
2021 (1)
- The Optimise Study: Vaccine preparedness. (PUBLIC HEALTH REPORT) Saich F, Heath K, Altermatt A, Merner B, Hill S, Pedrana A, Munari S, Horyniak D, Walker S, Wallace J, Block K, Gibbs L, Gibney K, Hellard M. The Optimise Study. March, 2021.
Reports and other work
-
The Optimise Study: Vaccine preparedness
This report focuses on:<br/>• Attitudes towards COVID-19 vaccines<br/>• Concerns about the vaccines<br/>• Information needs regarding COVID-19 vaccines and the rollout strategy<br/>
The Optimise Study: Vaccine preparedness
Burnet publications
View 41 moreOne size does not fit all: healthcare worker perspectives on hepatitis B models of care in a low-prevalence region in Australia
Australian and New Zealand Journal of Public Health
Joshua Richmond et al
Synthesising enablers and barriers to hepatocellular carcinoma surveillance—A systematic review of qualitative findings
PLoS ONE
Dina Moussa et al
The urgent need to end hepatitis B stigma and discrimination
The Lancet. Gastroenterology & hepatology
Catherine Freeland et al
Past projects
View 4 more
CHINA-B study: Cancer information compared to Hepatitis B information to INcreAse hepatitis B testing in Melbourne’s Chinese community
This pilot and feasibility study aimed to increase hepatitis B testing in Melbourne’s Chinese community.

The elimination of hepatitis C as a global public health threat
This project addresses critical knowledge gaps in Australian and global efforts to eliminate hepatitis C as a public health threat by 2030.

The Optimise Study: Optimising Isolation, Quarantine and Distancing for COVID-19
This project aims to find out how Victorians are experiencing COVID-19 and responding to the measures introduced to stop the spread of the virus.